bioExpert supports pharmaceutical and technology companies addressing needs in business development, drug discovery, and interim management. bioExpert has a focus on neurodegenerative diseases and protein related technologies. We have also effectively supported companies developing chemical technology, tissue culture, diagnostics, and drug discovery in other indications.

Our experience enables fast and effective solutions. Based on our vast network, we facilitate partnering, licensing, and company sale.


Business Development

Success relies on experience, insights and contacts.

bioExpert offers more than 20 years of hands-on experience in leading roles in pharma and biotech management, a continuously updated and extended network of more than 500 top rank industry contacts, drug discovery experience including early clinical trials, a track record of finding the right partner for technology deals, and more than 20 years of experience in negotiating licensing, collaboration and service deals. We wrote business plans and secured finances for start-ups.


Biotechnology Evaluation

Needs technical know-how, benchmarking and imagination.

bioExpert offers hands-on experience and leadership in drug discovery in the areas of proteopathic neurodegenerative diseases (AD, PD), and many other indications, in assay development (in vitro and in vivo), in protein expression, purification, and analytical characterization, and in molecular biology.

We will benchmark your technology or product to the competition and create market development plans. Our network of trustworthy and proven experts and service providers will support your project in any needed aspect.


The Neuro4D Conference

Focused, well organized conferences bring people together for new collaborations.

A focused conference that brings neurodegenerative disease experts together for new collaborations. bioExpert organizes the Neuro4D Conference, concentrating on evolving insights into proteopathic neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, ALS, Huntigton, etc, covering in vitro and in vivo models, preclinical drug discovery, and drug development for effective translation to the clinic.

The conference brings together 50-80 expert participants from drug discovery companies, service providers and academia, for open discussions and close interactions in a comfortable setting, facilitating personal contacts.